8-K: National Healthcare Properties Announces Estimated Per-Share NAV of $32.15 as of December 31, 2024
Current Report
National Healthcare Properties, Inc. announced that its board of directors approved an estimated per-share net asset value (NAV) of $32.15 as of December 31, 2024.
Summary
- National Healthcare Properties, Inc.'s board of directors approved an estimated per-share net asset value (NAV) of $32.15 as of December 31, 2024.
- The NAV was determined by considering appraisals of the company's real estate assets by Kroll, LLC, an independent valuation firm.
- Kroll provided a valuation range, and the board's selected NAV fell within that range.
- The calculation considered factors such as the decrease in fair values of same-store properties, the impact of a stock dividend issued in January 2024, and the four-for-one reverse stock split completed in September 2024.
- The board also considered dispositions and debt paydowns, the internalization of management functions, and broader market and industry trends.
- A sensitivity analysis showed that varying capitalization and discount rates could result in an Estimated Per-Share NAV range of $32.15 to $36.96 per share.
- Kroll used the Discounted Cash Flow Method for 155 properties, the Direct Capitalization Method for 10 properties, the Disposition Method for 16 properties, and the Sales Comparison Approach for one property.
- The NAV calculation divides the estimated value of real estate and other assets, less debt, other liabilities, and the liquidation value of preferred stock, by the number of common shares outstanding, which was 28,296,439 as of December 31, 2024.
- The company believes the assumptions used to estimate the value of the Real Estate Assets are within the ranges used by market participants buying and selling similar properties.
- The company cautions that the Estimated Per-Share NAV does not represent the price at which shares of common stock would trade at on a national securities exchange or a third party would pay for the Company.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While the company provides a detailed valuation update, the decrease in NAV compared to the previous year is a negative factor. The company's disclosures and risk warnings temper any positive sentiment.
Positives
- The board unanimously approved the Estimated Per-Share NAV.
- The company engaged an independent valuation firm, Kroll, to ensure objectivity.
- The company considered various factors, including market and industry trends, in determining the NAV.
- The company provides a sensitivity analysis to show the impact of varying capitalization and discount rates.
Negatives
- The Estimated Per-Share NAV is lower than the 2023 Estimated Per-Share NAV of $52.00.
- The company acknowledges that the Estimated Per-Share NAV does not represent the price at which shares of common stock would trade at on a national securities exchange or a third party would pay for the Company.
Risks
- The Estimated Per-Share NAV is based on estimates and assumptions that may not be accurate or complete.
- The market for commercial real estate can fluctuate, and values are expected to change in the future.
- The Estimated Per-Share NAV does not reflect a liquidity discount for the fact that the shares of common stock are not currently traded on a national securities exchange.
- The company acknowledges the general uncertainty in the capital markets, particularly the continued heightened interest rate environment and its impact of the Company's future liquidity and cash flows.
- Broad political and economic uncertainty for 2025 could impact the fair values of the company's portfolio.
Future Outlook
The company does not intend to declare any further stock dividends in the future.
Management Comments
- The Board based its conclusions on its review of the Company's analysis and recommendation, the Kroll Report, estimates and calculations and the fundamentals of the Real Estate Assets.
- The Board is ultimately and solely responsible for the Estimated Per-Share NAV.
Industry Context
This announcement is typical for non-traded REITs, which are required to provide periodic NAV updates to investors. The valuation methodology and disclosures are consistent with industry practices.
Comparison to Industry Standards
- The valuation methodology used by Kroll, including the Direct Capitalization Method and the Discounted Cash Flow Method, are standard practices in the commercial real estate industry.
- The company's engagement of an independent valuation firm and the detailed disclosures regarding the valuation process are consistent with best practices for non-traded REITs.
- Comparable companies in the non-traded REIT space, such as Blackstone Real Estate Income Trust (BREIT) and Starwood Real Estate Income Trust (SREIT), also provide periodic NAV updates and detailed disclosures regarding their valuation methodologies.
Stakeholder Impact
- The Estimated Per-Share NAV impacts shareholders by providing an updated valuation of their investment.
- The NAV may influence investor decisions regarding buying, selling, or holding shares.
- The NAV is used for internal purposes and may not be indicative of the price at which shares could be sold.
Key Dates
| Date | Description |
|---|---|
| December 31, 2023 | Date used for comparison of Real Estate Assets and other financial metrics. |
| January 16, 2024 | Last date on which Company issued dividends in the form of common stock valued at the Estimated Per-Share NAV in effect on the applicable date. |
| January 2025 | The Company repaid the Promissory Note in full including any unpaid interest at the time of payment. |
| February 27, 2024 | Date of the 2024 Form 10-K filing with the SEC. |
| September 2024 | Completion of the four-for-one reverse stock split of the common stock and internalization of the Company's management functions. |
| December 31, 2024 | Valuation Date for the Estimated Per-Share NAV. |
| March 26, 2025 | Date the Board unanimously approved the Estimated Per-Share NAV. |
Keywords
Estimated Per-Share NAV, Real Estate Assets, Valuation, Kroll, Preferred Stock, Common Stock, Healthcare Properties, NAV
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.